Get In-Depth Coverage.
Published loading...Updated

Insider Buying: Immuneering Corporation (NASDAQ:IMRX) CEO Buys 7,015 Shares of Stock

Summary by marketbeat.com
Immuneering Corporation (NASDAQ:IMRX - Get Free Report) CEO Benjamin J. Zeskind bought 7,015 shares of the firm's stock in a transaction that occurred on Wednesday, July 2nd. The shares were purchased at an average cost of $3.53 per share, for a total transaction of $24,762.95. Following the purchase, the chief executive officer owned 2,312,852 shares in the company, valued at $8,164,367.56. This represents a 0.30% increase in their position. Th…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Thursday, July 3, 2025.
Sources are mostly out of (0)